stockrow
Saturday 7 November 2026
Export JYNT’s income statement to Excel — free account
The Joint Corp.
JYNT Healthcare Medical Care Facilities
The Joint Corp.’s revenue for fiscal 2025 (year ended December 2025) was $54.9 million, up 5.24% from fiscal 2024.
- Revenue
- +14.4%
- EPS
- +400.0%
- Free cash flow
- +432.3%
Quarter to June 2026, against a year earlier
6.89
0.48
−6.51%
Follow JYNT
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
79.50 | 45.89 | 38.48 | 32.52 |
P/S ratio |
2.69 | 2.40 | 2.22 | 2.14 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
82.57 | 45.55 | (85.02) | 57.05 | |
P/B ratio |
6.44 | 8.75 | 8.10 | 7.88 | |
Price to Tangible BV |
7.92 | 12.17 | 11.15 | 10.75 | |
EV/Sales |
2.16 | 2.00 | 1.87 | 1.78 | |
EV/EBITDA |
120.11 | 137.04 | 44.79 | 33.11 | |
EV/Operating CF |
38.32 | 59.66 | 26.11 | 19.32 | |
EV/FCF |
(32.31) | (22.20) | (40.51) | (99.45) | |
Quick Ratio |
1.02 | 0.83 | 0.79 | 1.06 | |
Current Ratio |
1.83 | 1.59 | 1.64 | 1.83 | |
Net Debt/EBITDA |
(49.22) | (20.50) | (16.76) | (411.51) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.73 | 0.76 | 0.82 | 0.94 | |
Operating CF/Net income |
2.07 | 2.92 | (1.14) | 3.36 | |
Capex/Depreciation |
(0.69) | (0.79) | (0.58) | (0.60) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
75.57% | 73.65% | 72.89% | 81.96% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
2.59% | 2.15% | 1.89% | 2.79% | |
Graham Net Nets |
0.09 | 0.05 | 0.06 | 0.06 | |
Graham Number |
2.00 | 2.06 | 2.38 | 2.60 | |
Earnings Yield |
1.26% | 2.18% | 2.60% | 3.08% | |
Free Cash Flow Yield |
(2.49%) | (3.74%) | (2.09%) | (0.84%) | |
Revenue per Share |
0.87 | 1.00 | 1.05 | 1.07 | |
Operating CF per Share |
0.12 | 0.19 | (0.10) | 0.15 | |
Capex per Share |
(0.02) | (0.02) | (0.02) | (0.02) | |
Free Cash Flow per Share |
0.09 | 0.17 | (0.12) | 0.14 | |
Cash per Share |
2.00 | 1.61 | 1.51 | 1.61 | |
Shareholders Equity per Share |
1.48 | 1.00 | 1.09 | 1.11 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.48 | 1.00 | 1.09 | 1.11 | |
Free Cash Flow |
1.46 | 2.55 | (1.71) | 1.94 | |
Working Capital |
27.45 | 19.27 | 19.42 | 19.82 | |
Capital Expenditures |
(0.32) | (0.35) | (0.23) | (0.26) | |
Net Current Asset Value |
13.84 | 6.20 | 7.16 | 8.05 | |
EV/EBIT |
0.00 | 0.00 | 166.08 | 73.91 | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Price to Operating Income |
0.00 | 0.00 | 196.47 | 88.81 | |
| Other line items | |||||
Average Receivables |
3.60 | 2.72 | 2.66 | 2.60 | |
Average Payables |
1.55 | 1.67 | 0.99 | 1.34 | |
Average Assets |
74.49 | 72.06 | 69.01 | 62.41 | |
Average Common Equity |
21.60 | 17.88 | 19.17 | 19.57 |
Columns are period end dates · fundamentals updated 25 Oct 2026